Conference
545 A phase II randomized window of opportunity trial evaluating cytotoxic and immunomodulatory effects of intratumoral INT230-6 (cisplatin, vinblastine) in early stage breast cancer: the INVINCIBLE trial
Authors
Arnaout A; Robertson S; Keyhanian K; Awan A; Pond G; Bartlett J; Hopkins M; Liao L; Talebian V; Radvyani L
Pagination
pp. a570-a570
Publisher
BMJ
Publication Date
November 1, 2022
DOI
10.1136/jitc-2022-sitc2022.0545
Name of conference
Regular and Young Investigator Award Abstracts